Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Repotrectinib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114349648A details a one-step ruthenium-catalyzed reductive amination for high-purity chiral amines, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.